Metraipolis › archive › dc_ae1a8288ca2e

Personalized Drug Repurposing Screen Identifies Patient-Specific Therapeutic Candidates for Mucopolysaccharidosis Type IIIB — Europe PMC PMID:42506095

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42506095
DOI: 10.3390/jpm16070369
License (as archived): solo-consultazione
Archived: 2026-10-18T10:08:21.004Z
SHA-256 of the archived text: b2e33ef06f0e38e5b3dd68ef0d0c96dbcdf6ec30d8e3e92628441d3a78f590e7
Stable URL of this page: https://metraipolis.com/documento/dc_ae1a8288ca2e

How to cite

Personalized Drug Repurposing Screen Identifies Patient-Specific Therapeutic Candidates for Mucopolysaccharidosis Type IIIB — Europe PMC PMID:42506095 — Europe PMC (en), https://europepmc.org/article/MED/42506095 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ae1a8288ca2e (Metraipolis archive dc_ae1a8288ca2e, sha256 b2e33ef06f0e38e5b3dd68ef0d0c96dbcdf6ec30d8e3e92628441d3a78f590e7)

BibTeX

@misc{dcae1a8288ca2e,
  title = {Personalized Drug Repurposing Screen Identifies Patient-Specific Therapeutic Candidates for Mucopolysaccharidosis Type IIIB — Europe PMC PMID:42506095},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42506095},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ae1a8288ca2e; sha256 b2e33ef06f0e38e5b3dd68ef0d0c96dbcdf6ec30d8e3e92628441d3a78f590e7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42506095. Agents can read the archived copy with the MCP tool read_document.